Avivagen Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
G. F. Anthony
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.8yrs |
| CEO ownership | n/a |
| Management average tenure | 7.7yrs |
| Board average tenure | 15.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jul 31 2023 | n/a | n/a | -CA$5m |
| Apr 30 2023 | n/a | n/a | -CA$6m |
| Jan 31 2023 | n/a | n/a | -CA$6m |
| Oct 31 2022 | CA$400k | CA$361k | -CA$6m |
| Jul 31 2022 | n/a | n/a | -CA$6m |
| Apr 30 2022 | n/a | n/a | -CA$6m |
| Jan 31 2022 | n/a | n/a | -CA$7m |
| Oct 31 2021 | CA$539k | CA$469k | -CA$6m |
| Jul 31 2021 | n/a | n/a | -CA$6m |
| Apr 30 2021 | n/a | n/a | -CA$5m |
| Jan 31 2021 | n/a | n/a | -CA$5m |
| Oct 31 2020 | CA$420k | CA$362k | -CA$5m |
| Jul 31 2020 | n/a | n/a | -CA$5m |
| Apr 30 2020 | n/a | n/a | -CA$5m |
| Jan 31 2020 | n/a | n/a | -CA$5m |
| Oct 31 2019 | CA$412k | CA$362k | -CA$5m |
| Jul 31 2019 | n/a | n/a | -CA$5m |
| Apr 30 2019 | n/a | n/a | -CA$5m |
| Jan 31 2019 | n/a | n/a | -CA$5m |
| Oct 31 2018 | CA$431k | CA$363k | -CA$5m |
Compensation vs Market: Insufficient data to establish whether G. F.'s total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: G. F.'s compensation has been consistent with company performance over the past year.
CEO
G. F. Anthony (68 yo)
7.8yrs
Tenure
CA$399,892
Compensation
Mr. G. F. Kym Anthony has been Chief Executive Officer of Avivagen Inc. since May 2019 serves as its Director since April 4, 2014 and serves as its Vice Chairman since April 19, 2023. Mr. Anthony served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Vice Chairman | 7.8yrs | CA$399.89k | no data | |
| Co-Founder | 7.7yrs | CA$134.37k | no data | |
| Interim Chief Financial Officer | 2.3yrs | CA$120.38k | no data | |
| President and Executive VP of Business Development & Product Innovation | 2.9yrs | no data | no data | |
| Director of Investor Relations | 7.8yrs | no data | no data | |
| Director of Companion Animal & Marketing Manager | no data | no data | no data |
7.7yrs
Average Tenure
Experienced Management: VIVX.F's management team is seasoned and experienced (7.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Vice Chairman | 10.7yrs | CA$399.89k | no data | |
| Co-Founder | 19.3yrs | CA$134.37k | no data | |
| Member of Business & Technology Advisory Team | 15.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 17.8yrs | no data | no data | |
| Independent Chairman of the Board | 19.3yrs | CA$71.17k | no data | |
| Member of Business and Technology Advisory Team | 15.3yrs | no data | no data | |
| Independent Lead Director | 8.7yrs | CA$97.13k | no data | |
| Member of Business and Technology Advisory Team | 15.3yrs | no data | no data | |
| Member of Business and Technology Advisory Team | 15.3yrs | no data | no data | |
| Chairman of the Business and Technology Advisory Team | 15.3yrs | no data | no data | |
| Member of Business and Technology Advisory Team | 15.3yrs | no data | no data |
15.3yrs
Average Tenure
54yo
Average Age
Experienced Board: VIVX.F's board of directors are seasoned and experienced ( 15.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 20:21 |
| End of Day Share Price | 2024/10/02 00:00 |
| Earnings | 2023/07/31 |
| Annual Earnings | 2022/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Avivagen Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Doug Cooper | Beacon Securities Limited |
| Joseph Gomes | NOBLE Capital Markets, Inc. |
| David Bautz | Zacks Small-Cap Research |